Mr. Brent Saunders reports

BAUSCH + LOMB ANNOUNCES APPOINTMENT OF KAREN L. LING TO BOARD OF DIRECTORS

Karen L. Ling has been appointed to Bausch + Lomb Corp.'s board of directors, effective immediately. Current director Richard De Schutter will retire from the board effective as of the company's 2024 annual meeting of shareholders. With Ms. Ling's appointment, the board has been temporarily expanded to 11 members and is expected to revert to 10 directors following the annual meeting.

"Since my return to the company, Richard has been a trusted adviser," said Brent Saunders, chairman and chief executive officer, Bausch + Lomb. "I join the rest of the board in thanking him for his service and wishing him well as he pursues his many other interests."

Mr. Saunders continued: "With her extensive industry leadership experience and time as a public company director, Karen brings significant human capital management, corporate governance and shareholder engagement expertise to the organization. We're confident her perspectives will be highly additive in the boardroom as Bausch + Lomb continues its evolution."

Ms. Ling stated: "I have long admired Bausch + Lomb's reputation in eye health, and am excited to join such a dynamic and innovative organization as it executes an ambitious global growth strategy. I look forward to helping the company deliver value for all stakeholders in 2024 and beyond."

About Ms. Ling

Ms. Ling is the former executive vice-president and chief human resources officer at American International Group Inc. and, prior to that, at Allergan. She previously held senior human resources roles at Merck and Wyeth. Ms. Ling is currently a director and chair of the compensation and human capital management committee of iRythym Technologies and has served on the boards of Mallinckrodt PLC and TherapeuticsMD Inc. She also serves as a member of the advisory committee of Galderma. Additionally, Ms. Ling is a member of the board of two non-profits: ExpandEd Schools and the JED Foundation. She holds a BA in economics from Yale University and a JD from the Boston University School of Law.

About Bausch + Lomb Corp.

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world -- from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments.

We seek Safe Harbor.